About hearX®

About hearX®

Affordable access to hearing care through smart, digital health solutions

We don't just set industry standards; we redefine them

hearX is a vision-led, value-driven company at the forefront of revolutionizing audiological assessments and access to hearing healthcare.

Since our inception in 2016, we have remained committed to continuous innovation that stands as a beacon of transformative technologies which shape the hearing healthcare landscape.

Our portable, user-friendly screening and diagnostic products enable healthcare professionals to conduct accurate and clinically-validated hearing assessments on the go.

Our Values

People first

People first

Quality innovation

Quality innovation

Trust

Trust

As a key player in the audiological tech industry, we consistently set new benchmarks, offering unmatched value to audiologists, pharmaceutical companies, research organizations and businesses.

Our clients

Awards

Projects and partners

hearWho

hearWHO

Mobile app for hearing screening
Based on validated digits-in-noise technology, the hearWHO app was developed solely by hearX Group. It provides the general public access to a hearing screener to check their hearing status and monitor it over time. Screening languages include English, Mandarin and Spanish.

More than 263,800 app installs since its launch.

Höra

Höra

Mobile app to test, monitor and preserve hearing
In December 2019, the Fondation Pour l'Audition in France launched Höra, a mobile application for identifying hearing loss in only 3 minutes. The digits-in-noise test technology, developed by hearX Group, enables users to pre-screen for potential hearing loss. The French digit material in this product is owned by the Fondation Pour l'Audition and was recorded in collaboration with the University of Montpellier.

*Disclaimer: The French digit material in this product is licensed from the Fondation Pour l'Audition. The Fondation Pour l'Audition reserves all its rights in terms of the intellectual property and copyright of the digit material. www.fondationpourlaudition.org. The University of Montpellier collaborated on the recording of the French digit material.

Meet our Board of Directors

Prof De Wet Swanepoel

Prof De Wet Swanepoel

Professor of Audiology, University of Pretoria Editor-in-chief, International Journal of Audiology

Nic Klopper

Nic Klopper

CEO at hearX Group

Albert Lotter

Albert Lotter

Managing Director at Noise Clipper

Anders Kronborg

Anders Kronborg

CEO at ResoTher Pharma

Jordan Bernstein

Jordan Bernstein

Managing Director and General Counsel of CI Capital Partners, a New York based private investment firm

Frederick Iseman

Frederick Iseman

Chairman and CEO of CI Capital Partners, a New York based private investment firm

Jeremy Lim, MD

Jeremy Lim, MD

Health technology advisor, Agency for Science, Technology and Research (ASTAR), Singapore and Co-Director, Global Health, National University of Singapore Saw Swee Hock School of Public Health

Newsletter

hearX is committed to protecting your privacy and ensuring that personal information is collected and used lawfully and transparently. We use the information provided to contact you about relevant products, services and content. You may unsubscribe at any time. Privacy Policy

Press and mediaPublished researchCareersShipping and returnsPAIA manual
BlogImpact reportsContact usTerms and conditions
hearX Group info@hearxgroup.com US: +1 (415) 825-3064 RSA: +27 (0) 12 030-0268
Lexie Hearing sales@lexiehearing.com +1 (800) 499-1336
hearX is SOC2® compliant.

This globally recognized attestation validates our commitment to critical security standards to protect and secure client data

FDA Registered | ISO 13485 Certified | SAHPRA Registered | HIPAA Compliant | POPIA Compliant

To report unethical behavior, misconduct or harassment click here.

For any feedback or complaints, please contact: support@hearxgroup.com.

© 2016-2024 hearX IP (Pty) Ltd. Copyright in this work including its layout and the design contained herein is reserved and the making of copies is prohibited.